Statin-induced rhabdomyolysis: a cautionary tale for high-dose rosuvastatin
Keyword(s):
Statins are a widely prescribed lipid-lowering agent for preventing adverse cardiovascular events. However, a major side effect is rhabdomyolysis, a breakdown of muscle tissue, which can cause acute kidney injury and death. We present a case of a 77-year-old Chinese woman who was started on 40 mg rosuvastatin post-percutaneous coronary intervention and ultimately developed rhabdomyolysis and acute kidney injury one month later. This case highlights the need to consider patient risk factors for developing statin-induced rhabdomyolysis when choosing the right dose of statin to prescribe.
2014 ◽
Vol 63
(12)
◽
pp. A1812
2014 ◽
Vol 174
(2)
◽
pp. 440-441
◽
2021 ◽
Vol Publish Ahead of Print
◽
2016 ◽
Vol 67
(13)
◽
pp. 395